ÂÜÀòÂÒÂ×

John Sharp has over 25 years of experience in finance and accounting. John began their career in 1994 as a Senior Manager, Audit at PricewaterhouseCoopers. In 2000, they moved to Diversa Corporation as the Director of Accounting. In 2004, they joined Sequenom as the Vice President of Finance. After three years, they moved to Ligand Pharmaceuticals as the CFO. In 2014, they became the CFO at HUYA Bioscience International. In 2016, they joined PhaseBio Pharmaceuticals, Inc. as the Chief Financial Officer. John is currently the Chief Financial Officer at SaNOtize Research and Development Corp.

John Sharp attended San Diego State University.